| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72603-288-01 | 72603-288 | HUMAN PRESCRIPTION DRUG | Lubiprostone | lubiprostone | CAPSULE | ORAL | 20250701 | N/A | ANDA | ANDA218640 | Northstar Rx LLC | LUBIPROSTONE | .008 mg/1 | 60 CAPSULE in 1 BOTTLE (72603-288-01) |
| 72603-289-01 | 72603-289 | HUMAN PRESCRIPTION DRUG | Lubiprostone | lubiprostone | CAPSULE | ORAL | 20250701 | N/A | ANDA | ANDA218640 | Northstar Rx LLC | LUBIPROSTONE | .024 mg/1 | 60 CAPSULE in 1 BOTTLE (72603-289-01) |
| 31722-404-60 | 31722-404 | HUMAN PRESCRIPTION DRUG | Lubiprostone | lubiprostone | CAPSULE | ORAL | 20250527 | N/A | ANDA | ANDA218640 | Camber Pharmaceuticals, Inc. | LUBIPROSTONE | .024 mg/1 | 60 CAPSULE in 1 BOTTLE (31722-404-60) |
| 31722-403-60 | 31722-403 | HUMAN PRESCRIPTION DRUG | Lubiprostone | lubiprostone | CAPSULE | ORAL | 20250527 | N/A | ANDA | ANDA218640 | Camber Pharmaceuticals, Inc. | LUBIPROSTONE | .008 mg/1 | 60 CAPSULE in 1 BOTTLE (31722-403-60) |